德國WT1癌症疫苗，源自德國尖端醫學科研技術，專為癌症預防及免疫治療而設計。本疫苗透過精準激活人體樹突細胞（Dendritic Cells），引導免疫系統準確辨識並消滅帶有WT1抗原的癌細胞，達致長效防癌抗癌效果。臨床研究證明，WT1抗原在超過80%的惡性腫瘤中均呈高表達，令此疫苗擁有廣泛的適用性。

本疫苗療程安全簡便，只需3次注射，即可提供超過10年的持續性防護，有效降低癌症的發生、復發及轉移風險。特別適合亞健康、高癌症風險群組人士，包括有癌症家族史、長期處於高致癌風險環境或高壓力人士。更備有額外保障—若接種後五年內不幸確診癌症，即可獲得大額賠償保障，讓您安心無憂，全面守護健康。

🌟 產品特色

✅ 德國尖端科研技術，安全可靠
✅ 專業激活樹突細胞，有效抗癌
✅ 超過10年持續性免疫保護
✅ 超過80%癌症適用，強效廣譜防護
✅ 簡便三劑注射療程，無需特別準備
✅ 五年內若不幸確診癌症，提供大額賠償保障

🌟 適用癌症種類

包括但不限於：

• 胃癌、肺癌、肝癌、胰腺癌

• 乳腺癌、卵巢癌、子宮癌、子宮頸癌

• 前列腺癌、腎癌、膀胱癌

• 結直腸癌、食道癌

• 急性骨髓性白血病 (AML)、急性淋巴性白血病 (ALL)、慢性骨髓性白血病 (CML)、骨髓增生異常綜合症 (MDS)

• 惡性淋巴瘤、多發性骨髓瘤

• 腦腫瘤（腦膠質母細胞瘤等）

• 黑色素瘤、肉瘤及其他多種實體腫瘤

🌟 療程安排

• 療程次數： 共3次注射

• 療程間隔： 建議在第1個月、第2個月及第6個月各注射一次

• 服務地點： 香港指定高端醫療中心

• 額外保障： 五年內確診癌症可獲大額賠償

🌟 適合人士

• 希望預防癌症、提高免疫力人士

• 癌症家族史人士

• 長期處於高致癌風險環境或壓力大人士

• 癌症康復人士（預防復發與轉移）

🌟 注意事項

不適合以下人士：

• 孕婦及哺乳期婦女

• 器官移植病人

• 正在接受免疫抑制藥物治療人士

• 愛滋病患者

• 身體嚴重虛弱人士或急性發熱者

The German-developed WT1 Cancer Vaccine utilizes cutting-edge German medical technology specifically designed for cancer prevention and immune therapy. By precisely activating dendritic cells, this vaccine effectively trains the immune system to accurately recognize and eliminate cancer cells expressing the WT1 antigen, achieving long-term anti-cancer immunity. Clinical studies have demonstrated that WT1 antigen is highly expressed in over 80% of malignant tumors, allowing this vaccine to provide broad-spectrum protection.

This vaccine offers a convenient and safe three-dose regimen, providing sustained protection against cancer for over 10 years, significantly reducing risks of cancer development, recurrence, and metastasis. It is especially suitable for individuals with suboptimal health, high cancer risk, strong family history, or exposure to carcinogenic environments or chronic stress. Furthermore, substantial compensation is provided if cancer is unfortunately diagnosed within five years after vaccination, ensuring peace of mind and comprehensive health protection.

🌟 Product Highlights

✅ German Advanced Medical Technology – Safe and Reliable
✅ Precise Activation of Dendritic Cells – Effective Anti-cancer Immunity
✅ Over 10 Years Sustained Immune Protection
✅ Suitable for Over 80% of Cancer Types – Broad-spectrum Efficacy
✅ Convenient Three-Dose Regimen – Simple and Comfortable
✅ Substantial Compensation within 5 Years if Cancer Diagnosed

🌟 Applicable Cancer Types

Including but not limited to:

• Gastric Cancer, Lung Cancer, Liver Cancer, Pancreatic Cancer

• Breast Cancer, Ovarian Cancer, Cervical Cancer, Uterine Cancer

• Prostate Cancer, Kidney Cancer, Bladder Cancer

• Colorectal Cancer, Esophageal Cancer

• Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML), Myelodysplastic Syndrome (MDS)

• Malignant Lymphoma, Multiple Myeloma

• Brain Tumors (e.g., Glioblastoma)

• Melanoma, Sarcoma, and various solid tumors

🌟 Treatment Schedule

• Total Injections: 3 doses

• Injection Intervals: 1st month, 2nd month, and 6th month

• Service Location: Designated Premium Medical Centers in Hong Kong

• Additional Protection: Substantial compensation if diagnosed within 5 years post-vaccination

🌟 Suitable Population

• Individuals aiming for cancer prevention and immune enhancement

• Individuals with family history of cancer

• Those exposed to high-risk carcinogenic environments or chronic stress

• Cancer survivors aiming to prevent recurrence or metastasis

🌟 Precautions

Not suitable for:

• Pregnant and breastfeeding women

• Organ transplant recipients

• Individuals currently undergoing immunosuppressive therapy

• AIDS patients

• Severely debilitated individuals or those experiencing acute fever